About AtrogiAtrogi AB is a phase II-ready, Stockholm-based biotech company pioneering first-in-class oral treatments to revolutionize metabolic health. Our mission is to redefine the management of muscular wasting, obesity and type 2 diabetes, and other metabolic disorders affecting millions of people worldwide.Our proprietary GPCR discovery platform includes more than 40 granted patents and a library of over 1,000 proprietary compounds. Our lead candidate, ATR-258, is a first-in-class oral β₂-adrenergic receptor agonist designed to improve metabolism in fat and skeletal muscle cells without causing muscle loss or cardiovascular strain, and is now advancing into Phase II clinical evaluation. Find out more at www.atrogi.com.About the roleWe are looking for an experienced Chief Executive Officer to lead Atrogi through its next phase of clinical and corporate development, as the company advances its lead candidates towards and through Phase II trials and prepares to engage investors and partners internationally.As CEO, you will have overall responsibility for the company's strategic direction, operations and performance, and will act as the primary link between the Board of Directors, the management team, employees, investors and external partners.Key responsibilitiesSet and execute the company's overall strategy, in close cooperation with the Board of Directors, to advance Atrogi's clinical pipeline and corporate development.Lead and develop the management team and the wider organisation, fostering a strong scientific and collaborative culture.Take overall responsibility for the company's clinical development program, including progression of ATR-258 into and through Phase II trials.Lead fundraising efforts and investor relations, including engagement with existing and pr…

Chief Executive Officer (CEO)